Scientific Paper Proves Enhanced Terminal Room Disinfection Leads to Decreased HAI Rates

A recent scientific paper in the American Journal of Infection Control by leading researchers reviews the compendium of clinical evidence on and discusses the effectiveness of UV devices for terminal room decontamination. According to the "Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials" (Anderson, et al, 2016), two key findings were reported to validate the use and efficacy of no touch UV disinfection robots, such as Tru-D SmartUVC. Further, the researchers stressed the importance of well-controlled, large-scale, randomized, clinical trials versus small-scale before-and-after studies that lack monitoring of other infection prevention practices when comparing and contrasting such devices.
"The most studied device of its kind and the only UV robot validated by a CDC-funded, randomized, clinical trial, Tru-D pioneered and continues to remain the gold standard in the UV disinfection space," said Chuck Dunn, president and CEO of Tru-D SmartUVC. "This intensive literature review proves our focus on and dedication to independent, third-party research and validates that Tru-D technology is backed by sound science."

Among the key findings in the article, researchers concluded that, "improved terminal cleaning of rooms leads to a decreased rate of individual patient colonization and infection," and likewise, "improved terminal cleaning of rooms leads to a decreased facility-wide rate of colonization and infection." Meaning, healthcare environments have a direct impact on patient care and outcomes. The study continues to report that of the six hierarchies of research methods, randomized, clinical trials that remove any and all confounding factors have the greatest bearing on determining effectiveness of UV devices. In the UV disinfection space, Tru-D is the only device validated by a randomized, clinical trial.

Tru-D was the only UV device of its kind chosen for the first-ever, randomized, clinical trial on UV disinfection due to its patented Sensor360 technology that removes any chance of human error in the disinfection process. The Benefits of Enhanced Terminal Room Disinfection (BETR-D) study, which was funded by the Centers for Disease Control and Prevention and presented in abstract form at IDWeek 2015, proved that enhanced terminal room cleaning strategies decreased the cumulative incidence of multidrug-resistant organisms by up to 30 percent, and the largest decreases were seen when Tru-D was added to the standard protocols. Final results are undergoing peer-review and expected to be published in the near future.

Tru-D is an automated, remotely-operated UV disinfection system that self-adjusts to the size and content dynamics of any room to deliver a continuous, lethal dose of UVC light energy necessary for complete, total room disinfection. It works by generating and measuring UVC light to deliver a consistent dosage, which is proven to modify the DNA structure of infectious bacteria and spores such as C. diff, MRSA and VRE, and eliminate the risk of transmitting infections through contaminated surfaces. As energy is reflected around the room, shadowed areas are reached and pathogens are eradicated ensuring a thorough disinfection outcome, every time.

Source: Tru-D SmartUVC